Skip to main
PDEX
PDEX logo

Pro-Dex (PDEX) Stock Forecast & Price Target

Pro-Dex (PDEX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Pro-Dex Inc has demonstrated a positive financial trajectory, highlighted by a year-over-year revenue increase of 22%, attributed to the growth in new medical device product sales and repairs. The company's gross margins have also improved, reaching 33% year-over-year, indicating enhanced operational efficiency and profitability. Furthermore, the management's successful acquisition of new product contracts and investment in private label offerings are expected to continue fostering substantial growth in the future.

Bears say

Pro-Dex Inc. has recently adjusted its fiscal year 2025 revenue estimates to $67 million, a decrease from the previous estimate of $68 million, and revised its earnings per share (EPS) forecast downward to $2.81 from $2.30. This adjustment reflects potential challenges in meeting revenue goals amid a competitive landscape and evolving demand for technology in the medical device sector. Furthermore, risks stemming from macroeconomic factors, shifts in consumer sentiment, and the overall investor outlook for technology stocks may further hinder the company's financial performance and stock prospects.

Pro-Dex (PDEX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Pro-Dex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Pro-Dex (PDEX) Forecast

Analysts have given Pro-Dex (PDEX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Pro-Dex (PDEX) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Pro-Dex (PDEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.